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Key Points  
 
- The HADS is acceptable and feasible for use with mild to moderate dementia 
- Structural validity of HADS in dementia is unclear, making interpretation 
difficult.  
- It is, however, preferable to use the HADS to measure two factors of anxiety 
and depression rather than one single distress factor. 
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Abstract 
Objectives  
The Hospital Anxiety and Depression Scale (HADS) is a well-validated, self-report 
measure of both anxiety and depression. It is frequently used with people with 
dementia. However, its structural validity has never been examined in this population. 
The current study used confirmatory factor analysis (CFA) to assess this.  
Methods  
Baseline data from two intervention studies for people with mild to moderate 
dementia were combined (N = 268). CFA was used to test whether a one, two or three 
factor structure best fit the data. Indices of model misspecification were examined to 
test for poor quality items, and models re-specified accordingly. Finally, measurement 
invariance across gender and different levels of cognitive impairment was assessed. 
Results  
A one-factor structure did not fit the data. Two and three factor structures fitted the 
data equally well. Model fit was improved by removal of two items. Measurement 
invariance was adequate across gender, but poor across groups with differing levels of 
cognitive impairment.  
Conclusion 
The HADS is acceptable and feasible but difficult to interpret in a dementia 
population. We suggest that it should be interpreted as measuring two separate factors 
of anxiety and depression and not one ‘distress’ factor. However, two items may need 
to be removed, affecting cut-off scores. Poor measurement invariance means the 
HADS may not be a good tool for measuring differences in anxiety and depression 
between those with mild and those with moderate cognitive impairment.  
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Introduction 
Depression and anxiety are common yet under-diagnosed comorbidities in dementia 
(Enache et al., 2011, Wolitzky‐Taylor et al., 2010) and are associated with negative 
outcomes (Gibbons et al., 2002). Self-rating of mood in those with cognitive 
impairment is complex (Feher et al., 1992). However, dementia diagnosis is now 
typically made at an earlier stage in disease progression with associated increased 
self-awareness (Grimmer et al., 2015). Self-report measures are therefore increasingly 
relevant for people with dementia and are particularly useful for measuring mood in 
people with dementia who have no available informant (Alzheimer's Association, 
2012).  
The Hospital Anxiety and Depression Scale (HADS) (Zigmond and Snaith, 1983) is a 
14-item self-report measure of anxiety and depression. It is appealing for use in 
dementia as it is relatively brief, measures both anxiety and depression and can be 
used in those with comorbid physical health problems. Evaluation of measurement 
properties of the HADS in dementia is important, given its use in clinical practice and 
dementia research (e.g. Clare et al. (2012)) 
The utility of any measure stands or falls on its reliability and validity, both of which 
are multi-faceted constructs. The HADS performs well on some aspects of validity 
and reliability across different populations, for example, those with physical health 
problems or psychiatric inpatients (Bjelland et al., 2002).  
Structural validity, the degree to which item scores are an adequate reflection of 
dimensional structure is an important aspect of validity without which measurements 
cannot be adequately interpreted (Mokkink et al., 2010). Evidence for structural 
validity of the HADS in populations without dementia is mixed, with studies 
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suggesting that the HADS measures one single ‘distress’ factor  (Razavi et al., 1990), 
separate ‘anxiety’ and ‘depression’ factors (Zigmond and Snaith, 1983) or even three 
factors, following Clark and Watson (1991)’s tripartite model of anxiety, depression 
and negative affectivity (Cosco et al., 2012).  
While the structural validity of the HADS has not been specifically examined in a 
dementia population, work in a medically-hospitalised older sample (Helvik et al., 
2011) and a cognitively-intact nursing home sample (Haugan and Drageset, 2014) 
favours a two-factor structure. Such findings are not generalizable to a dementia 
population (Cosco et al., 2012), as anxiety and depression present differently 
(Banerjee et al., 2011) and some items (e.g. the fourth item on the depression subscale 
(I feel slowed down)) may be confounded by cognitive functioning (Haugan and 
Drageset, 2014). The current study seeks to inform the use of and interpretability of 
the HADS in dementia through assessment of its structural validity in a dementia 
sample. 
Method 
Participants 
Data analysed in this study were the combined baseline data for participants with mild 
to moderate dementia (diagnosed according to DSM-IV) taken from two clinical 
trials, one examining home based support for people with dementia (Orrell et al., In 
press), and the other CBT for anxiety in dementia (Spector et al., 2015). The 
recruitment procedures and samples for these trials have been described in detail 
elsewhere (Orrell et al., In press, Spector et al., 2015). All participants in both trials 
gave written informed consent. Ethical approval was obtained from ‘East London 3 
Research Ethics Committee’ (reference number 10/H0701/124) for use of the Spector 
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et al. (2015) data and from the Outer North East London Research Ethics Committee  
(reference number: 09/H0701/54) for use of the Orrell et al. (In press) data.  
 
Age, gender, Mini Mental State (MMSE)(Folstein et al., 1975) scores and dementia 
diagnosis (only recorded in the Orrell et al. (In press) study) of the combined sample 
are presented in Table 1.  
The HADS 
The HADS comprises 14 items each rated from 0-3, with higher scores indicating 
greater anxiety/depression. The anxiety and depression subscales each have seven 
items and a maximum score of 21. (Zigmond and Snaith, 1983) 
Statistical Analyses  
Confirmatory factor analysis (CFA) was used to test the fit of the HADS data from 
the combined dataset with the three most commonly proposed factor structures: the 
two-factor model of Zigmond and Snaith (1983), the one-factor model of Razavi et al. 
(1990), and the three-factor non-hierarchical model of Dunbar et al. (2000). Diagrams 
illustrating these models are shown in Figure 1.  
- Insert Figure 1 about here- 
CFA was performed in R(version 3.2.2) (R Core Team, 2013) statistical software 
using Lavaan (Rosseel, 2012) semplots and semtools packages (SemTools 
Contributors, 2015). 
Indices of model fit 
In line with the literature (Hu et al., 1992, Dunbar et al., 2000), model fit was assessed 
by several indices with cut-off scores used to determine good, adequate or poor fit.  
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Two of the indices used here - the Standardized Route Mean Square Residual 
(SRMR) and the Root Mean Square Error of Approximation (RMSEA) - have cut-off 
scores of good fit, <0.05; adequate fit, <0.08; and poor fit > 0.08. Two of the others - 
the Comparative Fit Index (CFI) and the Tucker Lewis Index (TLI) - have cut-off 
scores of good fit, >0.95; adequate fit, >0.9 and poor fit, <0.9. The final index, the 
Bayesian Information Criterion (BIC), is a comparative fit index, with no cut-off. 
Specification searching  
Fit indices should be supplemented with information about how well individual items 
fit within a CFA model (Byrne, 2013). Here, items with standardised residuals with 
values in excess of 2.58 and high modification indices were classified as misspecified 
(Byrne, 2013). Both standardised residuals and modification indices were used to 
adapt and improve, or ‘re-specify’, models through specification searching (Byrne, 
2013). To avoid undue influence being given to the idiosyncracies of a particular data 
set, a priori concerns were used to drive specification searching (Byrne, 2013).  
Measurement invariance  
Measurement invariance of the HADS is necessary if it is to be used to test for 
differences in anxiety and depression across particular subgroups of people with 
dementia. Measurement invariance is assumed if individuals in different groups with 
the same levels of the latent construct have the same expected raw-score on the 
measure (Drasgow and Kanfer, 1985). To test for measurement invariance of the 
HADS, the data were split into subgroups according to gender and cognitive 
impairment. In line with evidence relating MMSE to stage of dementia (Perneczky et 
al., 2006), mild impairment was defined as MMSE > 21 and compared to a moderate 
impairment subgroup (MMSE < 20). Following this the models were examined for 
the different types of measurement invariance (configural, metric, strong and strict) 
8 
 
through comparison of progressively more constrained models, with a change in CFI 
greater than 0.01 taken to indicate change in model fit across constraints and therefore 
lack of invariance between groups (Chen, 2007).  
Results 
Data characteristics and initial analyses 
Of the combined dataset (N = 339), 65 participants did not attempt the HADS. Of 
those who attempted the HADS, six were ‘non completers’ (missing data for one or 
more items).  
The data were examined for differences in gender, age and MMSE scores between 
those who completed, attempted and did not attempt the HADS. Chi square was used 
to test for differences in gender and ANOVA for differences in MMSE and age.  
Groups did not differ for gender or age but did differ in MMSE, (F2,304 = 25.97 
p<0.001) with planned comparisons revealing that non attempters had lower MMSE 
scores than completers (Games Howell MD = -7.25, p<0.001 ).  
For those who attempted the HADS (N= 274), Little’s MCAR test revealed that data 
were missing completely at random (χ2 = 50.48 (36), p = 0.06). Under these 
circumstances, listwise deletion of cases with missing data is acceptable (Graham, 
2009). Consequently only those with full data available (N=268) were subject to 
CFA.  
The final CFA sample consisted of 125 males (47%), 142 (52.9%) females and one 
unstated, mean age was 69 years (Standard Deviation of 12.3) and mean MMSE score 
was 19.8 (standard deviation, 5.4). Descriptive data for the HADS items are shown in 
Table 1. Graphical inspection and significant Shapiro Wilk tests for all HADS items 
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indicated significant univariate non-normality, with the sample generally reporting 
low levels of depression and anxiety and consequent positive skew. Mardia’s test 
indicated significant multivariate non normality (χ2 skew = 1784.7, p<0.001, Z  
Kurtosis = 26.2, p<0.001). Given this non-normal ordinal data, the CFA approach of 
Maximum Likelihood (ML) methods with Satorra Bentler corrected (robust) chi 
square was used to examine fit of all models (Finney and DiStefano, 2006). 
- Insert Table 1 about here -   
Confirmatory Factor Analysis results 
Parameter estimates 
Parameter estimates were deemed adequate using Byrne (2013)’s  three criteria: 
consistency with underlying theory, values falling inside admissible ranges, and 
parameters being statistically significant.  
Initial model fit 
Table 2 shows the fit indices for all three models. None of the models show a good fit 
with the data, with the one factor model performing particularly poorly across all 
indices. The two and three factor models both performed similarly and adequately on 
three indices (SRMR, CFI, RMSEA) but were poor on one (TLI).  
Specification searching 
Given the mixed evidence as to the adequacy of fit of the two and three factor models 
but lack of difference in fit between them, specification searching (examination of 
modification indices and standardized residuals) of the two and three factor models 
was conducted to understand sources of model misspecification. This was first done 
in relation to item four on the depression subscale ‘I feel slowed down..’, which had 
been specified a priori, as potentially problematic. The highest modification indices 
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in the two factor (31.7) and three factor models (31.9) were associated with cross-
loadings of this item onto latent variables other than depression (anxiety and negative 
affectivity). Additionally, in both models, this item was associated with the largest 
standardized residual covariance values (5.16, in the three factor model and 5.01 in 
the two factor model) and also the highest number of these in excess of 2.58 (five in 
both the two and three factor models). Given clear evidence that this item was a 
source of misspecification, it was removed from the analyses, which were then re-run 
with results and fit indices detailed in Table 2. The fit of both two and three-factor 
models was improved, such that indices of fit were now ‘adequate’ for some fit 
indices (TLI, CFI) and ‘good’ for others (RMSEA, SRMR). There was, however, still 
no discrimination between the models, with both models having almost identical fit 
indices.  
- Insert Table 2 about here -   
On inspection, the fourth item on the anxiety subscale (‘I can sit at ease and feel 
relaxed’) was associated with the next highest modification indices (22.1 in the 3 
factor model, 23.1 in the 2 factor model) and next highest number of standardized 
residuals above 2.58 (three) in both the two and three factor models. While there was 
not an a priori reason for removing this item, given some evidence of 
misspecification, it was removed (along with the fourth item on the depression 
subscale) for an exploratory analysis (with results and fit indices detailed in Table 2). 
Removing item four on the anxiety scale improved model fit in both two and three 
factor models with all indices now suggestive of ‘good fit’. However, once more there 
was no difference between models.   
Measurement invariance  
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In order to assess whether the HADS can be validly used to measure differences in 
depression and anxiety across groups who differ in cognitive functioning or gender, 
we assessed measurement invariance of the HADS across these groups. Measurement 
invariance assessment was conducted on both the two and three factor models with 
the fourth item of the depression subscale removed (the models with the fourth item 
on the anxiety subscale also removed were not subjected to this analysis as the 
removal of this item was exploratory). The data were first divided into subgroups 
according to gender (male N = 142) and separately by MMSE score. For five 
participants, MMSEs were missing so the sample size for this analysis was 263, with 
N = 142 falling into the low MMSE group and N=121 into the high MMSE group.   
The results of the analysis of the different types of invariance (configural, metric, 
strong and strict) are shown in Table 3. Measurement invariance of the HADS was 
adequate across groups who differ in gender but inadequate across MMSE categories. 
Specifically, the data indicate that for groups differing according to gender, configural 
invariance criteria were adequate for CFI (three-factor 0.91, two-factor 0.91) and 
RMSEA (three-factor 0.071, two-factor 0.069) and criteria for all other invariance 
types were met with CFI change always more than 0.01. For groups differing in 
cognition, the high cognition group for the three-factor model had a non-positive 
definite covariance matrix, meaning that it was difficult to interpret invariance for this 
model, and measurement invariance could not be assumed. For the two factor model, 
the configural invariance assumption was not met (CFI of 0.88 and a RMSEA of 
0.081) although measurement invariance was demonstrated across all other levels 
(CFI∆<0.01) aside from strict invariance where CFI∆ = 0.013.  
- Insert Table 3 about here -   
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Discussion 
This study suggests that people with mild to moderate dementia can complete the 
HADS, but raises concerns about the structural validity and consequent interpretation 
of HADS scores in dementia.  
A single distress factor? 
In line with previous CFA studies in other populations (Haugan and Drageset, 2014, 
Cosco et al., 2012) we found no evidence that the HADS measures a single distress 
factor. We suggest that it should not be interpreted in this way in people with 
dementia in clinical or research contexts. 
Structural ambiguity and pragmatic use of a two factor model 
We could not distinguish between two interpretations of the HADS; that it measures 
two factors of ‘anxiety’ and ‘depression’ or that it measures three factors of anxiety, 
depression and negative affectivity. The inability to distinguish between different 
interpretations has been termed ‘structural ambiguity’ (Wang et al., 2006) and makes 
understanding HADS scores in dementia difficult.  
Structural ambiguity has been found with the HADS in other populations (Wang et 
al., 2006) and is in line with the general lack of clarity over HADS structure (Cosco et 
al., 2012). This has led some authors to advocate abandoning it altogether (Coyne and 
van Sonderen, 2012). One strategy for deciding between structural models is to favour 
the most parsimonious structure. However, fit indices used in the current study (e.g. 
BIC) take model parsimony into account (Neath and Cavanaugh, 2012) and did not 
indicate that the two factor structure should be preferred. A strategy to disambiguate 
in future research would be to test the indices derived from the two and three factor 
structures for other forms of validity (e.g. concurrent or criterion validity) in a 
13 
 
dementia sample and to see which performs best. Until this research has been done, 
we suggest that, if the HADS is to be used in dementia, a two-factor interpretation 
might be preferred due to its greater simplicity of scoring. Given this and that fit 
indices are so similar for two and three factor models, the rest of this discussion will 
focus on the two-factor interpretation.  
Removal of items 
Model fit was improved by removal of two items (the fourth items on the anxiety and 
depression subscales). The prediction that the fourth item on the depression subscale 
(I feel slowed down…) would be confounded by cognitive impairment was supported 
by the poor fit of this item coupled with its relatively high mean score, which could 
reflect individuals endorsing it due to cognitive impairment regardless of depression. 
It was more surprising that the fourth item on the anxiety scale (I can sit at ease and 
feel relaxed) did not relate to the underlying construct of anxiety. This may be a data 
idiosyncrasy but has been found before (Haugan and Drageset, 2014) and warrants 
further consideration.  
 Given their poor fit to the data, we suggest that HADS users should definitely 
remove the fourth item on the depression scale and consider removing the fourth item 
on the anxiety subscale in scoring the HADS for people with dementia. The removal 
of one or both of these items will affect the ability to use HADS cut-offs for anxiety 
and depression caseness, so we suggest that future work with the HADS in dementia 
could also focus on developing cut-offs for shortened HADS subscales excluding 
these items.  
Measurement invariance 
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The measurement invariance data suggest that, in a dementia population, differences 
in mean HADS scores between moderate and milder impairment groups may be un-
interpretable. This is because such differences may be due either to between group 
variation in the relationship of raw HADS scores to the latent constructs of anxiety 
and depression or to between group differences in anxiety and depression themselves 
(Xu, 2012). The implication of this is that research using the HADS to examine 
differences in anxiety and depression between mild and moderate impairment groups 
will be hard to interpret. Similarly, in clinical work, where normative reference 
groups differ in the degree of cognitive impairment to a patient with dementia, HADS 
scores will be difficult to meaningfully understand. As measurement invariance is 
better across gender, comparisons in HADS scores between men and women with 
dementia can be performed.   
Strengths and limitations 
This is the first study to examine the structural validity of the HADS in dementia. A 
strength is the use of a CFA approach to test hypotheses as to which structure 
proposed in the literature best fits in a dementia sample. Some limitations require 
noting. The mean score on HADS items was low. Future work should examine this 
measure in samples where there is more variance and higher levels of depression and 
anxiety. Dementia is an umbrella term and factor structure may differ across specific 
dementia diagnoses, which have different patterns of impairment. For example, those 
with behavioural variant Fronto-Temporal Dementia may lack insight (Rosen et al., 
2014) and under-report anxiety or depression. We did not have the data to examine 
this, but future research is recommended. A number of individuals in the Orrell et al. 
(in press) study did not attempt the HADS, and were excluded from the analysis. 
Consequently, these results are only representative of those people with dementia who 
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attempt the HADS not the dementia population as a whole. The higher MMSE scores 
of attempters compared to non-attempters suggests that this population may have 
higher cognitive functioning, although there were attempters with very low MMSE 
scores, indicating low MMSE scores should not be used to rule out use of the HADS.  
Our relatively small sample size (for a CFA study) may result in the structural 
ambiguity found here (Wang et al., 2006). Replication with a larger sample is 
recommended. Finally, although the most frequently proposed structures in the 
literature were evaluated, not all potential HADS structures were considered. Future 
research should examine the bi-factor structure (Norton et al., 2013) and the impact of 
measurement artefacts (Straat et al., 2013). Item Response Theory studies may be 
useful to conduct in a dementia population as these provide strong evidence of latent 
variable structure, with the particular advantage of being generalizable beyond a 
population (Cosco et al., 2012). 
 
Conclusions 
This study suggests that the HADS is feasible for use in dementia, but is difficult to 
interpret. The HADS should not be used to measure one factor of ‘distress’ in this 
population. While two and three factor structures are equally supported here, we 
suggest that the HADS is used to measure two factors of anxiety and depression for 
simplicity of scoring. Two HADS items may not be useful in a dementia population 
and further work is needed to develop cut-off scores for a reduced item version. Lack 
of measurement invariance means that the HADS may not be suitable to measure 
differences in anxiety and depression where groups differ in level of cognitive 
impairment. 
16 
 
  
17 
 
References 
 
Alzheimer's Association 2012. 2012 Alzheimer’s disease facts and figures. 
Alzheimer's & Dementia, 8, 131-168. 
Banerjee, S., Hellier, J., Dewey, M., Romeo, R., Ballard, C., Baldwin, R., Bentham, 
P., Fox, C., Holmes, C. & Katona, C. 2011. Sertraline or mirtazapine for 
depression in dementia (HTA-SADD): a randomised, multicentre, double-
blind, placebo-controlled trial. The Lancet, 378, 403-411. 
Bjelland, I., Dahl, A. A., Haug, T. T. & Neckelmann, D. 2002. The validity of the 
Hospital Anxiety and Depression Scale: an updated literature review. Journal 
of psychosomatic research, 52, 69-77. 
Byrne, B. M. 2013. Structural equation modeling with AMOS: Basic concepts, 
applications, and programming, Routledge. 
Chen, F. F. 2007. Sensitivity of goodness of fit indexes to lack of measurement 
invariance. Structural equation modeling, 14, 464-504. 
Clare, L., Nelis, S. M., Martyr, A., Roberts, J., Whitaker, C. J., Markova, I. S., Roth, 
I., Woods, R. T. & Morris, R. G. 2012. The influence of psychological, social 
and contextual factors on the expression and measurement of awareness in 
early‐stage dementia: testing a biopsychosocial model. International journal 
of geriatric psychiatry, 27, 167-177. 
Clark, L. A. & Watson, D. 1991. Tripartite model of anxiety and depression: 
psychometric evidence and taxonomic implications. Journal of abnormal 
psychology, 100, 316. 
Cosco, T. D., Doyle, F., Ward, M. & McGee, H. 2012. Latent structure of the 
Hospital Anxiety And Depression Scale: a 10-year systematic review. Journal 
of psychosomatic research, 72, 180-184. 
Coyne, J. C. & van Sonderen, E. 2012. The Hospital Anxiety and Depression Scale 
(HADS) is dead, but like Elvis, there will still be citings. Journal of 
Psychosomatic Research, 73, 77-78. 
Drasgow, F. & Kanfer, R. 1985. Equivalence of psychological measurement in 
heterogeneous populations. Journal of Applied Psychology, 70, 662. 
Dunbar, M., Ford, G., Hunt, K. & Der, G. 2000. A confirmatory factor analysis of the 
Hospital Anxiety and Depression scale: comparing empirically and 
theoretically derived structures. British Journal of Clinical Psychology, 39, 
79-94. 
Enache, D., Winblad, B. & Aarsland, D. 2011. Depression in dementia: epidemiology, 
mechanisms, and treatment. Current opinion in psychiatry, 24, 461-472. 
Feher, E. P., Larrabee, G. J. & Crook, T. H. 1992. Factors attenuating the validity of 
the Geriatric Depression Scale in a dementia population. Journal of the 
American Geriatrics Society, 40, 906-909. 
Finney, S. J. & DiStefano, C. 2006. Non-normal and categorical data in structural 
equation modeling. Structural equation modeling: A second course, 269-314. 
Folstein, M. F., Folstein, S. E. & McHugh, P. R. 1975. “Mini-mental state”: a 
practical method for grading the cognitive state of patients for the clinician. 
Journal of psychiatric research, 12, 189-198. 
Gibbons, L. E., Teri, L., Logsdon, R., McCurry, S. M., Kukull, W., Bowen, J., 
McCormick, W. & Larson, E. 2002. Anxiety symptoms as predictors of 
nursing home placement in patients with Alzheimer's disease. Journal of 
Clinical Geropsychology, 8, 335-342. 
Graham, J. W. 2009. Missing data analysis: making it work in the real world. Annu 
Rev Psychol, 60, 549-76. 
18 
 
Grimmer, T., Beringer, S., Kehl, V., Alexopoulos, P., Busche, A., Förstl, H., 
Goldhardt, O., Natale, B., Ortner, M. & Peters, H. 2015. Trends of patient 
referral to a memory clinic and towards earlier diagnosis from 1985–2009. 
International Psychogeriatrics, 27, 1939-1944. 
Haugan, G. & Drageset, J. 2014. The Hospital Anxiety and Depression Scale—
Dimensionality, reliability and construct validity among cognitively intact 
nursing home patients. Journal of affective disorders, 165, 8-15. 
Helvik, A.-S., Engedal, K., Skancke, R. H. & Selbæk, G. 2011. A psychometric 
evaluation of the Hospital Anxiety and Depression Scale for the medically 
hospitalized elderly. Nordic journal of psychiatry, 65, 338-344. 
Hu, L.-t., Bentler, P. M. & Kano, Y. 1992. Can test statistics in covariance structure 
analysis be trusted? Psychological bulletin, 112, 351. 
Mokkink, L. B., Terwee, C. B., Patrick, D. L., Alonso, J., Stratford, P. W., Knol, D. 
L., Bouter, L. M. & de Vet, H. C. 2010. The COSMIN study reached 
international consensus on taxonomy, terminology, and definitions of 
measurement properties for health-related patient-reported outcomes. Journal 
of clinical epidemiology, 63, 737-745. 
Neath, A. A. & Cavanaugh, J. E. 2012. The Bayesian information criterion: 
background, derivation, and applications. Wiley Interdisciplinary Reviews: 
Computational Statistics, 4, 199-203. 
Norton, S., Cosco, T., Doyle, F., Done, J. & Sacker, A. 2013. The Hospital Anxiety 
and Depression Scale: a meta confirmatory factor analysis. J Psychosom Res, 
74, 74-81. 
Orrell, M., Hoe, J., Charlesworth, G., Russell, I., Challis, D., Moniz-Cook, E., Knapp, 
M., Woods, B., Hoare, Z., Aguirre, E., Toot, S., Streater, A., Crellin, N., 
Whitaker, C. J. & D'Amico, F. In press. The support at Home - Interventions  
to Enhance Life in Dementia (SHIELD). Final Grant Report for the NIHR  
Perneczky, R., Wagenpfeil, S., Komossa, K., Grimmer, T., Diehl, J. & Kurz, A. 2006. 
Mapping scores onto stages: mini-mental state examination and clinical 
dementia rating. The American Journal of Geriatric Psychiatry, 14, 139-144. 
R Core Team 2013. R: A language and environment for statistical computing. R 
Foundation for Statistical Computing. 
Razavi, D., Delvaux, N., Farvacques, C. & Robaye, E. 1990. Screening for adjustment 
disorders and major depressive disorders in cancer in-patients. Br J 
Psychiatry, 156, 79-83. 
Rosen, H. J., Alcantar, O., Zakrzewski, J., Shimamura, A. P., Neuhaus, J. & Miller, B. 
L. 2014. Metacognition in the behavioral variant of frontotemporal dementia 
and Alzheimer’s disease. Neuropsychology, 28, 436. 
Rosseel, Y. 2012. Lavaan: An R Package for Structural Equation Modeling. Journal 
of Statistical Software, 48, 1-36. 
SemTools Contributors 2015. semTools: Useful tools for structural equation 
modeling. R package version 0.4-9. . Retrieved from http://cran.r-
project.org/package=semTools. 
Spector, A., Charlesworth, G., King, M., Lattimer, M., Sadek, S., Marston, L., Rehill, 
A., Hoe, J., Qazi, A. & Knapp, M. 2015. Cognitive–behavioural therapy for 
anxiety in dementia: pilot randomised controlled trial. The British Journal of 
Psychiatry, 206, 1-8. 
Straat, J. H., van der Ark, L. A. & Sijtsma, K. 2013. Methodological artifacts in 
dimensionality assessment of the hospital anxiety and depression scale 
(HADS). J Psychosom Res, 74, 116-21. 
19 
 
Wang, W., Lopez, V. & Martin, C. R. 2006. Structural ambiguity of the Chinese 
version of the Hospital Anxiety and Depression Scale in patients with 
coronary heart disease. Health Qual Life Outcomes, 4, 6. 
Wolitzky‐Taylor, K. B., Castriotta, N., Lenze, E. J., Stanley, M. A. & Craske, M. G. 
2010. Anxiety disorders in older adults: a comprehensive review. Depression 
and anxiety, 27, 190-211. 
Xu, K. 2012. Multiple group measurement: invariance analysis in Lavaan. Cambridge 
Mass, 37. 
Zigmond, A. S. & Snaith, R. P. 1983. The hospital anxiety and depression scale. Acta 
Psychiatr Scand, 67, 361-70. 
 
 
20 
 
Conflict of interest 
None declared  
21 
 
 
  
Table 1 showing sample characteristics and descriptive statistics of HADS items 
 N(%) Mean SD Skew Kurtosis Shapiro 
Wilk  
       
SAMPLE CHARACTERISTICS       
Male 125(48)      
Age  69.1 12. 3    
MMSE  19.8 5.4    
Dementia Diagnosis        
Not recorded (all participants in the Spector et al. 
(2015)  trial and those with missing data in the 
Orrell et al. (In press) trial.) 
70 (26)      
Alzheimer’s disease 109 (40)      
Vascular dementia 27(10)      
Frontotemporal dementia 3(1.1)      
Lewy Body Dementia 3(1.1)      
Any other type of dementia 23(8.6)      
HADS ITEMS       
1. I feel tense or 'wound up'  .74 0.78 1.07 1.029 0.769 
2. I still enjoy the things I used to enjoy  .81 0.93 0.95 -.011 0.787 
3. I get a sort of frightened feeling  .72 0.92 0.98 -.174 0.754 
4. I can laugh and see the funny side of things  .51 .781 1.49 1.520 0.675 
5. Worrying thoughts go through my mind  .75 .893 1.06 .308 0.769 
6. I feel cheerful  .56 .750 1.35 1.569 0.715 
7. I can sit at ease and feel relaxed  .78 .799 0.87 .320 0.796 
8. I feel as if I have slowed down  1.19 .905 0.69 -.175 0.816 
9. I get a sort of frightened feeling  .54 .751 1.40 1.656 0.707 
10. I have lost interest in my appearance  .58 .829 1.30 .706 0.706 
11. I feel restless as if I have to be on the move  .87 .888 0.74 -.287 0.816 
12. I look forward with enjoyment to things  .68 .961 1.22 .296 0.709 
13. I get sudden feelings of panic  .68 .793 1.04 .575 0.768 
14. I can enjoy a good book or radio or TV 
program 
 .53 .901 1.70 1.825 0.625 
Note N was 268 for all items, as were degrees of freedom for Shapiro Wilk test. All Shapiro Wilk statistics were 
significant p<0.001. 
22 
 
Table 2. Fit indices of original and respecified versions of one factor, two factor and three 
factor models 
Model 
χ2 
(robust) 
Df Srmr Cfi TLI Rmsea  (90% CI) BIC 
One factor  203.70 77 0.076 0.799  0.763 0.078 (0.067-0.089) 8831.78 
Two factor 
original 
135.90 76 0.066 0.905 0.886 054 (0.04-0.067) 8738.06 
Two factor 
without HADD4 
99.20 64 0.055 0.939 0.926 0.045 (0.030-0.060) 8047.85 
Two factor 
without HADD4 
or HADA4 
70.10 53 0.042 0.967 0.959 0.035 7452.36 
Three factor 
original 
132.40 74 0.065 0. 907 0.886 0.054 (0.041-0.067) 8746.52 
Three factor 
without HADD4  
96.40 62 0.054 0.941 0.925 0.045 (0.030-0.060) 8056.73 
Three factor 
without HADD4 
or HADA4 
67.69 51 0.043 0.968 0.959 0.035 (0.009-0.053) 7460.95 
Note: SRMR _ standardized root mean residual ( <0.05 suggests good fit, <0.08 suggests adequate fit, 
>0.08 suggests poor fit); CFI _ comparative fit index (>0.95 suggests good fit, >0.9 suggests adequate 
fit, <0.9 suggests poor fit); TLI_tucker Lewis Index (> 0.95 indicates good fit, >0.9 suggests adequate 
fit, <0.9 suggests poor fit ); RMSEA _ root mean square error of approximation (< 0.05 is good fit,  
<0.08 is adequate fit, >0.08 is poor fit) CI_confidence interval; BIC_ Bayesian information criterion; 
HADD4, Fourth item on the depression subscale; HADA4, fourth item on the anxiety subscale.  
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Table 3. Series of model comparisons to test measurement invariance of two and three factor models 
Subgroup Model Invariance 
type 
χ2 (∆χ2) DF 
(∆DF) 
∆p CFI(∆CFI) RMSEA 
Gender Two factor 
model without 
HADD4 
Configural 210.77 128 N/A 0.910 0.069 
Metric (13.25) 11 (0.277) (0.002) NA 
Strong (17.71) 11 (0.088) (<0.001) NA 
Strict (7.83) 2 (0.020) (0.002) NA 
 
Three factor 
model without 
HADD4 
Configural 207.05 124 N/A 0.909 0.071 
Metric (12.69) 10 (0.241) (0.003) NA 
Strong (17.81) 10 (0.058) (0.009) NA 
Strict (8.00) 3 (0.046) (0.005) NA 
 
MMSE Two factor 
model without 
HADD4 
Configural 238.63 128 N/A 0.884 0.081 
Metric (8.88) 11 (0.632) (0.002) NA 
Strong (25.07) 11 (0.009) (0.015) NA 
Strict (36.67) 2 (0.102) 0.003 NA 
 
Three factor 
model without 
HADD4 
Configural 229.80 124 N/A 0.889 0.081 
Metric (9.346) 10 (0.499) (0.001) NA 
Strong (22.026) 10 (0.015)* (0.013)* NA 
Strict (7.843) 3 (0.049) (0.005) NA 
Note: For configural invariance fit indices CFI _ comparative fit index (>0.95 suggests good fit, >0.9 suggests 
adequate fit, <0.9 suggests poor fit), RMSEA _ root mean square error of approximation (< 0.05 is good fit,  
<0.08 is adequate fit, >0.08 is poor fit). For all other invariance types, ΔCFI < 0.01 implies that the 
invariance assumption still holds. 
* indicates that invariance assumption is not met according to these criteria.  
 
 
 
